Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease

NCT05896670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: licaminlimab
OTHER: vehicle of OCS-02
OTHER: Artificial tears

Sponsor

Oculis

Collaborators

[object Object]